Background-Acute bacterial meningitis (ABM) remains a significant cause of pediatric illness and death in low and middle income countries (LMICs). Identifying severity risk factors and predictive scores may guide interventions to reduce poor outcomes.
Introduction
Acute bacterial meningitis (ABM) remains a significant cause of disability and mortality in children worldwide, accounting for an estimated 180,000 child deaths annually (1) . Since the introduction of Haemophilus influenzae type b (Hib) immunization in industrialized nations in the 1990s, and two decades later in most low and middle-income countries (LMICs), a substantial reduction of meningitis has been observed (2) . More recently, introductions of new vaccines against at least 13 Streptococcus pneumoniae (Spn) serotypes and Neisseria meningitidis (Nmn) have furtherreduced the burden of bacterial meningitis in high income nations (1, 3) . Despite the significant progress in decreasing the burden of bacterial meningitis globally, Hib and Spn continue to cause significant morbidity and mortality in LMICs where vaccine coverage is suboptimal or where vaccines are not yet introduced (1) (2) (3) . Characterizing risk factors for poor outcome among children with ABM could help clinicians to more effectively triage the limited therapeutic and rehabilitative resources available at health care facilities in LMICs. Risk factors for poor outcome in patients with meningitis have been described, but few studies have sought to create cumulative models capable of predicting outcome (4, 5) . Predictive models have the advantage of using several individual clinical variables to create a scale of risk with greater discriminatory power. Several complex scales have been proposed for industrialized countries, but few have been validated in LMICs, especially in Latin America (5, 6) . The Herson-Todd Score (HTS) was developed in the United States to predict death or major neurologic morbidity among children with Hib ABM (7). Other than a single center study in Angola, it has received minimal validation outside of the US (5). Therefore, we utilized a large disease surveillance database that included pediatric cases of meningitis diagnosed in Guatemala City over a decade to describe and identify risk factors for poor outcome, especially modifiable risk factors that may offer opportunities for intervention. We also validated the Herson-Todd Score in predicting death or major morbidity for this population.
Material and Methods

Study Population
Active surveillance was performed for all children 0-59 months of age admitted to three public referral hospitals in Guatemala City from 2000-2007. The three hospitals-Hospital General San Juan de Dios (HGSJD), Hospital Roosevelt, and Hospital General del Instituto Guatemalteco de Seguridad Social (IGSS)-account for approximately 85% of pediatric hospital admissions in Guatemala City. The remaining children are seen at private hospitals not included in the public surveillance program.
Within the surveillance system, a case of meningitis was defined as a child with clinically compatible illness and a) positive cerebrospinal fluid (CSF) culture for a pathogenic organism; or b) positive latex agglutination (LA) for Hib, Spn, or Nmn in CSF; or c) CSF white cell count > 10 cells/mL. For the purposes of this outcome prediction analysis, we defined a case of ABM as any child diagnosed with meningitis and a) positive culture for a bacteria considered pathogenic; or b) positive CSF LA; or c) CSF white cell count > 100 cells per mL as defined by the World Health Organization (8) . Outcomes were prospectively categorized during hospitalization as 1) dead or 2) survived with major morbidity (hydrocephaly, convulsions, cerebral stroke -infarct or thrombosis, or cranial nerve paralysis), or 3) survived without major morbidity. The final dataset used to determine clinical prediction scores and validate the HTS was limited to children with complete clinical and outcome data.
Herson-Todd Score (HTS)
The following variables were collected and weighted: presence of coma diagnosed by a clinician (3 points), hypothermia (temperature on admission less than 36.6 C) (2 points), seizure (2 points), shock diagnosed by clinician (1 point), age under 12 months (1 point), CSF white blood cell (WBC) count less than 1000 cells/mL (1 point), hemoglobin (Hb) less than 11 g/dL (1 point), CSF glucose less than 20 mg/dL (0.5 points), and symptoms more than 3 days at admission (0.5 points) (7) . Minor modifications in the original HTS were required due to limitations in clinical outcome data; the original score determined shock as systolic blood pressure < 60 mm Hg and severe coma specifically as apnea, non-reactive dilated pupils, and no response to pain, but was otherwise the same as our scoring system. The total HTS was calculated by adding the points for individual symptoms, for a maximum possible score of 12 points.
Statistical Analyses
Statistical analyses were conducted using SAS v 9.4 (SAS Institute Inc., Cary, NC). Baseline demographic and epidemiologic characteristics were compared using χ 2 tests.
Univariate odds ratios and p values were calculated to determine the ability of risk factors present at hospital admission to predict outcome during hospitalization (4, 5, 7, 9-11) for the following variables: age < 12 months, male gender, wet season, antibiotic use prior to hospital presentation, Hib vaccination (if ≥2 months of age), pathogen type (Hib, Spn or other non-contaminant), symptom duration > 3 days, temperature < 36.6°C at admission, seizure, coma, shock, positive CSF gram stain, CSF glucose < 20 mg/dL, Hb < 11 g/dL, and Herson-Todd score ≥ 5. A forward step-wise multiple logistic regression was then performed. All variables which were described in the univariate analyses were considered for inclusion in the multivariate analysis, except the Herson-Todd score and Hib vaccine status. A significance level of 0.3 was required to allow a variable into the multivariate model, and a significance level of 0.2 was required for a variable to stay in the multivariate model.
Each cut-off score (0-12) was assessed individually for its ability to predict poor outcomes. "High" scores, defined as having a total score greater than or equal to a pre-determined cutoff, were compared to "low" scores, defined as having a score below a pre-determined cutoff, for all possible scores. Sensitivity, specificity, and likelihood ratios were calculated for each cut-off in predicting outcome. Receiver operating characteristic (ROC) curves were plotted using sensitivity and specificity for each HTS cutoff score, and the area under the curve (AUC) was calculated. Following the analysis of all possible cut-offs, a HTS of ≥ 5 was utilized for the primary analysis. The AUC for a HTS ≥ 4 was approximately the same as a HTS ≥ 5. We selected a HTS cutoff of > 5 as a predictor of poor outcomes in the univariate analysis to prioritize specificity over sensitivity in this resource-limited context.
Ethical Approvals
This study received approval by the institutional review boards at the Johns Hopkins Bloomberg School of Public Health (Baltimore, USA) and the Hospital San Juan de Dios and Roosevelt Committees of Research and Ethics Review (Guatemala City, Guatemala).
Results
During the surveillance period, 811 illnesses among 809 children 0-59 months of age met criteria for ABM. We randomly excluded one episode each for the two children with two admissions, leaving only one episode per child in the analysis dataset. Of the 809 children with ABM, 800 had outcome information available: 387 (47.8%) survived their hospitalization without major morbidity, 221 (27.3%) survived with major morbidity, and 192 (23.7%) died. Among the children meeting the surveillance ABM definition, 417 were excluded because of missing data needed for calculating the HTS, leaving 383 (47.3%) for analysis. Of those children missing data, 398 (95.4%) had no information for at least six of the nine variables used to calculate the HTS. The most common missing variables were temperature (n = 401), coma (n = 400), seizure (n = 399), anemia (n = 399), symptom duration (n = 399), and shock (n = 398). Excluded children were more likely to be younger than 12 months (p = 0.01), admitted during the dry season (p = 0.002), and survive without major morbidity (p < 0.001, Table 1 ).
Baseline characteristics varied by clinical outcome group, including young age (p = 0.01), admitting hospital (p < 0.001), and organism isolated (p < 0.001) ( Table 2) . Of 100 and 76 vaccine-eligible (> 2 months old) children with Hib and Spn ABM, respectively, 98 (98%) and 73 (96%) were completely unvaccinated. In the multivariate analysis, adjusted predictors of poor outcome included seizure (OR 101.5, p < 0.0001), CSF glucose under 20 mg/dL (OR 5.3, p< 0.001), coma (OR 6.3, p = 0.004), and symptoms greater than 3 days (OR 3.7, p = 0.003); age under 12 months was protective on univariate (OR: 0.4, p = 0.004) but not multivariate analysis ( Table 3) .
As the Herson-Todd Score increased, risk of death or major morbidity for ABM also increased (AUC = 0.76; Table 4 and Figure 1) . A HTS score of 5 or greater was strongly associated with poor outcome in the univariate analysis (OR 10.3, p < 0.001, sensitivity 70%, specificity 82%).
Discussion
ABM remained a significant cause of morbidity and mortality in Guatemalan children before the introduction of Hib and Spn vaccines in 2005 and 2012, respectively. More than half of the children with ABM died or had major morbidity by hospital discharge. A HersonTodd Score of > 5 on admission strongly predicted death or major morbidity.
The most striking predictor of poor outcome was seizure (p < 0.0001), which has been previously observed as a significant risk factor for both death and morbidity (12) . Low CSF glucose (< 20 mg/dL), coma, and symptom duration were also strongly associated with increased risk of death or major morbidity. Several previous studies support these findings (7, (13) (14) (15) (16) (17) . While a CSF glucose concentration under 40 mg/dL (hypoglycorrachia) is found in most cases of ABM, it can also be found in viral meningitis (18, 19) . However, a CSF glucose concentration of less than 20 mg/dL offers more objective and specific measure of ABM severity and is unlikely due to other causes (18) . Prolonged symptoms prior to presentation were strongly associated with poor outcome, representing a potentially modifiable risk factor to improve public awareness and earlier detection. This may explain why children with ABM admitted to IGSS -a social insurance health care system that allows free access to care earlier in their course of illness -had significantly better outcomes than children admitted to the other hospitals. Interestingly, others have found that a shorter disease history actually correlated with a faster time (< 8 hours) to patient death, though not to mortality rate overall (20) . It is likely that some cases of fulminant meningitis leading to pre-hospital death were not captured in our surveillance study.
The Herson-Todd Score performed similarly in Guatemala to other meningitis scoring systems used in LMICs. The Glasgow Coma Scale (GCS) and Blantyre Coma Scale (BCS) were originally designed for traumatic coma in adults and cerebral malaria in children, respectively, but are also used for ABM (5, 17, 21) . More recently, Pelkonnen et al. designed the Simple Luanda Scale (SLS), which includes several clinical predictors and the absence of electricity as risk factors for poor outcome (5). Subsequently the Bayesian Luanda Scale (BLS), a more complex score including serum glucose concentration was shown to be more accurate than the SLS. In a 5-way comparison of scales, they found that the BLS (AUC 0.84) and SLS (AUC 0.82) were the most predictive, and that the HTS (AUC 0.72) was least predictive of death or major morbidity. Our findings among this population of children in Guatemala show a slightly better predictive performance of the HTS (AUC 0.76).
Our study has several important strengths. The study sample was large, and risk factors were collected prospectively for several years. Although we excluded many patients for missing data, the sample population reflected the spectrum of ABM in children admitted to Guatemalan hospitals. The high morbidity and mortality we observed was similar to other LMIC with high rates of ABM. We validated the HTS for all-cause ABM, expanding its relevance to other pathogens beyond Hib as well as a distinct patient population. Some limitations of this study must also be acknowledged. Surveillance was conducted in 2000-2007 before introduction of Hib and Spn vaccines, and though ABM remains a common problem in Guatemala, whether the score is applicable to meningitis to other pathogens will need to be revisited. Our database did not include information on tuberculosis testing, a potentially important etiology of ABM. The surveillance system did not record the use of corticosteroids, a potential modifier of severe outcomes, though this practice was not standard of care in Guatemala at the time of the study. Our case definition included a CSF WBC > 100 cells/mL and did not require identification of an organism, which may include children with non-bacterial meningitis, buy nonetheless reflects current recommended guidelines by WHO for global meningitis surveillance (8) .
Earlier recognition of ABM is one way of improving treatment outcomes but its potential is restricted by health system and access limitations within LMICs. When children do present with ABM, a scoring system validated in a low-income country that predicts outcome and allows health providers to estimate prognosis may improve deployment of limited therapeutic resources (e.g. steroids, intensive care treatment, etc.). Over 90% of vaccineeligible children with Hib and Spn ABM were unvaccinated during the period of surveillance, and thus improved access to vaccines against these organisms is likely to be the most practical and effective intervention to reduce morbidity and mortality from bacterial meningitis. 
